Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial

Faster, Cleaner, Better.

Ultrashort Nasdaq Biotechnology -2X ETF (BIS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

ETF Comparison for [[ item.sessionDateDisplayLong ]]

Results

Want to compare other data? Select Fields

Symbol	BIS
Company	Ultrashort Nasdaq Biotechnology -2X ETF
Price Information
Exchange	NASDAQ
Open	9.16
High	9.28
Low	9.08
Latest	9.26
Change	+0.04
% Change	+0.39%
Volume	10,300
20-Day Average Volume	13,385
Previous Close	9.22
Industry	N/A
Has Options	Yes
Technicals
20-Day Moving Average	9.12
20-Day Raw Stochastic	53.21%
20-Day Relative Strength	52.13
Weighted Alpha	-47.81
Today's Opinion	40% Sell
Previous Opinion	40% Sell
Last Month's Opinion	100% Sell
Performance
5-Days
%Chg	-1.72% since 03/19/26
Low	9.08 on 03/26/26
High	10.00 on 03/24/26
1-Month
%Chg	+8.15% since 02/26/26
Low	8.41 on 02/27/26
High	10.00 on 03/24/26
3-Month
%Chg	+1.29% since 12/26/25
Low	8.31 on 02/25/26
High	10.00 on 03/24/26
6-Month
%Chg	-32.38% since 09/26/25
Low	8.31 on 02/25/26
High	13.60 on 09/29/25
Key Statistics
Market Capitalization, $K	2,777
Shares Outstanding, K	300
Annual Sales	0
Annual Net Income	0
Last Quarter Sales	N/A
Last Quarter Net Income	N/A
60-Month Beta	-1.34
Per-Share Information
Most Recent Earnings	N/A
Latest Earnings Date	N/A
Most Recent Dividend	0.069 on 03/25/26
Next Ex-Dividends Date	03/25/26
Ratios
Price/Earnings ttm	0.00